<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gwack J</submitter><funding>Fund of Biomedical Research Institute, Jeonbuk National University Hospital</funding><funding>This paper was supported by Fund of Biomedical Research Institute, Jeonbuk National Univer-sity Hospital.</funding><pagination>5010-5022</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11119902</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>46(5)</volume><pubmed_abstract>Numerous hereditary ophthalmic diseases display significant genetic diversity. Consequently, the utilization of gene panel sequencing allows a greater number of patients to receive a genetic diagnosis for their clinical manifestations. We investigated how to improve the yield of genetic diagnosis through additional gene panel sequencing in hereditary ophthalmic diseases. A gene panel sequencing consisting of a customized hereditary retinopathy panel or hereditary retinitis pigmentosa (RP) panel was prescribed and referred to a CAP-accredited clinical laboratory. If no significant mutations associated with hereditary retinopathy and RP were detected in either panel, additional gene panel sequencing was requested for research use, utilizing the remaining panel. After additional gene panel se</pubmed_abstract><journal>Current issues in molecular biology</journal><pubmed_title>Improving the Yield of Genetic Diagnosis through Additional Genetic Panel Testing in Hereditary Ophthalmic Diseases.</pubmed_title><pmcid>PMC11119902</pmcid><funding_grant_id>0</funding_grant_id><pubmed_authors>Gwack J</pubmed_authors><pubmed_authors>Park J</pubmed_authors><pubmed_authors>Kim N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Improving the Yield of Genetic Diagnosis through Additional Genetic Panel Testing in Hereditary Ophthalmic Diseases.</name><description>Numerous hereditary ophthalmic diseases display significant genetic diversity. Consequently, the utilization of gene panel sequencing allows a greater number of patients to receive a genetic diagnosis for their clinical manifestations. We investigated how to improve the yield of genetic diagnosis through additional gene panel sequencing in hereditary ophthalmic diseases. A gene panel sequencing consisting of a customized hereditary retinopathy panel or hereditary retinitis pigmentosa (RP) panel was prescribed and referred to a CAP-accredited clinical laboratory. If no significant mutations associated with hereditary retinopathy and RP were detected in either panel, additional gene panel sequencing was requested for research use, utilizing the remaining panel. After additional gene panel se</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-08T19:43:08.852Z</modification><creation>2026-04-08T14:20:41.686Z</creation></dates><accession>S-EPMC11119902</accession><cross_references><pubmed>38785568</pubmed><doi>10.3390/cimb46050300</doi></cross_references></HashMap>